Lamivudine and therapeutic vaccine evaluation in Senegalese patients with chronic hepatitis B infection
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Lamivudine (Primary) ; Hepatitis B vaccine recombinant
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms HEPADAK-2
- 31 Aug 2018 Biomarkers information updated
- 31 Mar 2008 Status change from recruiting to discontinued, due to poor patient recruitment, as reported by clinicaltrials.gov.
- 05 Dec 2005 New trial record.